Key Takeaways What you need to know
  1. The SAP Clean Core principle is transforming CGT companies' ERP landscapes by minimizing custom modifications, which enhances operational scalability amid rapid growth in the $27 billion CGT market. This matters because it enables companies to maintain compliance and innovate faster as regulatory scrutiny increases.

  2. Many CGT organizations are grappling with technical debt from excessive SAP customizations that hinder scalability and complicate integration. This impacts not only IT departments but also operational efficiency as companies shift from clinical trials to commercial launches.

  3. Embracing the Clean Core approach allows CGT companies to differentiate their processes without compromising agility. It encourages intentional customization for business differentiation and regulatory needs, ensuring systems evolve in sync with the fast-paced advancements in cell and gene therapy.

Cell and Gene Therapy companies must adopt SAP’s Clean Core architecture to enhance operational scalability and regulatory compliance by minimizing customizations while allowing differentiation through modular extensions, as the industry rapidly grows and navigates complex manufacturing and logistical challenges.